level of consciousness on Glasgow coma scale was 15, there was jaundice, the hands were tremulous and her BP and pulse rate were 110/60 mm Hg and 120b/min and regular respectively. On 3rd day of admission, her level of consciousness on Glasgow coma scale became 8, temperature was 105°F and the patient was tachypneic and lungs were clear. Her laboratory test showed CBC with ESR and peripheral blood picture were normal, serum creatinine -0.8mg/dl. Blood and urine culture were sterile. Liver function test showed serum bilirubin-10.85 mg/dl, SGPT-48U/L , ALP-170U/L, prothrombin time-17sec. Screening for hepatitis A,B,C,E were negative. Ultrasound of the abdomen showed no abnormality. Her CXR P/A view, ECG and endoscopy of upper GIT were normal. Autoimmune markers such as antinuclear antibody were negative. Thyroid hormone levels showed:-TSH-<0.25mIU/L (N:0.3-5.0 mIU/L), T3-6nmol/L (N:1.23-3.54 nmol/L), T4-360 nmol/L (N:54-173 nmol/L). Thyroid scan and auto antibody tests could not be performed because of her moribund condition. The patient was treated as thyrotoxic crisis with antithyroid drugs, glucocorticoids and beta blocker. Unfortunately the patient expired on the 4th day of admission.
Discussion
Thyroid storm or crisis represents exaggerated manifestations of thyrotoxicosis. 5 Cardinal features include fever, tachycardia (usually out of proportion to the degree of fever), central nervous system manifestations (varying from confusion to coma), and gastrointestinal dysfunction with nausea, vomiting, or even jaundice in severe cases, which usually denotes a poor prognosis. [6] [7] Hyperglycemia, hypercalcemia , and LFT abnormalities are frequent findings .7-8 A precipitating factor usually decompensates hyperthyroidism; this can be an infection, trauma, surgery, cerebrovascular accident, or even emotional stress. Most patients have obvious symptoms and signs of thyrotoxicosis and a history of untreated or partially treated hyperthyroidism. 7, 9 The co-occurrence of hyperthyroidism and abnormal liver function tests is rare and the mechanism underlying hepatic dysfunction is not well known. In etiology, enzyme induction and the role of venous congestion due to heart failure are stipulated. Hypoxia is known as another mechanism and it is anticipated that increased oxygen utilization cannot be totally compensated for by hepatic blood flow. In patients with high levels of T3 and T4, relatively severe hypoxemia develops and the pericentral parts of hepatic acini become prone to damage. The mechanism underlying hyperbilirubinemia is not well known either and there are no available data supporting the direct toxic effects of thyroid hormones on the liver. 10 Jaundice can be diagnosed during the clinical course of thyrotoxicosis while mild increases are observed in ALT, AST and bilirubin levels. In a study by Thompson et al. abnormal function tests and, in particular, elevations of bilirubin were reported in hyperthyroidism. 11 In thyrotoxicosis, the predominant cardiac complications are atrial tachyarrhythmias and heart failure. Atrial fibrillation is the most common, occurring in 10% to 22% of hyperthyroid patients. Heart failure leading to hepatic congestion causes clinically detectable jaundice. As well as atrial fibrillation produces thrombi which clogs the hepatic circulation and produces ischemic liver which manifests as jaundice. 12 Studies assessing the incidence of embolic events in thyrotoxic patients who have atrial fibrillation have yielded conflicting information regarding the incidence of embolism . [13] [14] In the largest retrospective study, it appears that thyrotoxic patients who have atrial fibrillation are not at greater risk for embolic events, compared with age-matched patients who have atrial fibrillation due to other causes . 14 The standard risk factors for embolic events in atrial fibrillation, including increased age and underlying heart disease, apply to thyrotoxic patients.
Antithyroid drugs have been reported to induce liver toxicity but usually in the form of acute hepatitis with elevation of parenchymal enzymes. [15] [16] The occurrence of acute cholestasis is rare, although it is associated more commonly with carbimazole than with propylthiouracil. Hepatotoxicity, mainly in the form of cholestasis, has been reported in six cases of carbimazole use and in one of propylthiouracil use. 17, 21, 22 Only one study reported that cross reactivity of the two drugs caused hepatotoxicity. 21 In Woeber's review previously published cases of patients who had developed hepatotoxicity following treatment with MMI and carbimazole were analyzed; 19 patients had cholestatic-form clinical presentations. Clinical improvement is slow, yet the condition is totally reversible. An analysis of the cases reported by Woeber demonstrated that advanced age and high-dose anti-thyroid medications were risk factors for cholestatic damage. 23, 24 The liver has an important role in metabolism of thyroid hormone, and autopsies have shown hepatic inflammation, fibrosis, and centrilobular necrosis in patients with hyperthyroidism. 25 The pathogenesis of hepatic dysfunction is unknown; one theory suggests the liver is damaged by the systemic effects of excess thyroid hormone. Hyperthyroidism induces an increased metabolic rate, which is associated with increased oxidative capacity and oxidative damage of tissue. 26 Thyroid hormones are also known to increase production of insulin-like growth factor within the liver and can cause changes in fatty acid and lipid synthesis. 27 This hypermetabolic state makes the liver more susceptible to injury, and, in addition, thyroid hormones might also have a direct toxic effect on hepatic tissue.
Other associations between liver dysfunction and thyroid disease per se or its management are also well described. Autoimmune hepatitis is associated with autoimmune thyroid disease, and raised aminotransferase concentrations may be seen before thyroiditis is diagnosed. 28 If these persist after correction of thyroid dysfunction, liver biopsy may be required to differentiate autoimmune hepatitis from liver involvement secondary to thyroid disease as immunosuppressive therapies are usually indicated for autoimmune hepatitis.
A strong association exists between Hashimoto's thyroiditis and primary biliary cirrhosis. 29 In those affected, autoimmune thyroid failure might occur associated with the presence of thyroid microsome, thyroperoxidase, and thyroglobulin antibodies in addition to the presence of goitre. Patients with these antibodies or hypothyroidism (either clinical or biochemical), or both, may be found in a considerable number of those with primary biliary cirrhosis.
Conclusion
Thyroid hormone concentrations are important for normal hepatic function and metabolism of bilirubin. Lack of knowledge of the association between thyroid and liver abnormalities can lead to misdiagnosis, mistakes in management of patients, and consequent under-reporting of those patients affected. Published case series in those with hyperthyroidism show that results of liver tests can be severely abnormal and modest abnormalities are common. In certain individuals this can lead to serious morbidity and even mortality.
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